✦ LIBER ✦
Safety and tolerability of efalizumab therapy: A phase IIIb open-label study including patients using concurrent topical or phototherapy or recently transitioning from nonbiologic systemic psoriasis therapies
- Book ID
- 116580501
- Publisher
- Elsevier Science
- Year
- 2005
- Tongue
- English
- Weight
- 47 KB
- Volume
- 52
- Category
- Article
- ISSN
- 1097-6787
No coin nor oath required. For personal study only.